USFDA fast track designation allows expedited review of potential therapies to treat serious conditions and fill an unmet medical need. Among other benefits, companies whose investigational products are granted FTD are eligible for more frequent interactions with the USFDA during clinical development and potentially accelerated approval and priority review.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/i1d63YZ
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment